Alpha Teknova, Inc. (TKNO) compared with its closest peers (ICCC, BMRA, IMDX, AMS, XGN). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
ImmuCell, Biomerica, Insight Molecular Diagnostics, Myriad Genetics and Neogen share Alpha Teknova's sub-industry, diagnostics makers.
| Company | Market Cap | P/E |
|---|---|---|
| ImmuCell Corporation (ICCC) | $89.88M | 114.2 |
| Biomerica, Inc. (BMRA) | $10.05M | -1.4 |
| Insight Molecular Diagnostics Inc. (IMDX) | $131.55M | -4.5 |
| American Shared Hospital Services (AMS) | $9.74M | -9.1 |
| Exagen Inc. (XGN) | $181.92M | -6.6 |
| Personalis, Inc. (PSNL) | $1.79B | -8.8 |
| OmniAb, Inc. (OABI) | $731.31M | -3.2 |
| Biodesix, Inc. (BDSX) | $286.57M | -1.5 |
| Myriad Genetics, Inc. (MYGN) | $309.90M | -1.6 |
| Neogen Corporation (NEOG) | $2.57B | -224.1 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
TKNO overview · TKNO earnings · TKNO financials · TKNO KPIs · TKNO documents · TKNO ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.